718 related articles for article (PubMed ID: 18625444)
1. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
Thivolet C; Khallouf E
Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
6. The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children.
Jonson CO; Lernmark A; Ludvigsson J; Rutledge EA; Hinkkanen A; Faresjö M
Pediatr Diabetes; 2007 Aug; 8(4):185-92. PubMed ID: 17659059
[TBL] [Abstract][Full Text] [Related]
7. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
[TBL] [Abstract][Full Text] [Related]
8. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.
Durinovic-Belló I; Boehm BO; Ziegler AG
J Autoimmun; 2002 Feb; 18(1):55-66. PubMed ID: 11869047
[TBL] [Abstract][Full Text] [Related]
9. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
[TBL] [Abstract][Full Text] [Related]
10. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
[TBL] [Abstract][Full Text] [Related]
11. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
12. [The demonstration and specificity of autoreactive T-lymphocytes in type-1 diabetes].
Lohmann T; Scherbaum WA
Dtsch Med Wochenschr; 1997 Jun; 122(23):737-42. PubMed ID: 9229550
[TBL] [Abstract][Full Text] [Related]
13. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
Faresjö MK; Vaarala O; Thuswaldner S; Ilonen J; Hinkkanen A; Ludvigsson J
Diabetes Metab Res Rev; 2006; 22(6):462-70. PubMed ID: 16572494
[TBL] [Abstract][Full Text] [Related]
14. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
15. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
17. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
[TBL] [Abstract][Full Text] [Related]
18. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
[TBL] [Abstract][Full Text] [Related]
19. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
20. The potential of multimer technologies in type 1 diabetes prediction strategies.
Fierabracci A
Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]